000			01997 a2200577 4500
005			20250516185702.0
264		0	_c20140811
008			201408s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdt483 _2doi
040			_aNLM _beng _cNLM
100	1		_aDimopoulos, M A
245	0	0	_aSignificant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJan 2014
300			_a195-200 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aFemale
650	0	4	_aGlomerular Filtration Rate
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMultiple Myeloma _xcomplications
650	0	4	_aMultivariate Analysis
650	0	4	_aProportional Hazards Models
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aRenal Insufficiency _xetiology
650	0	4	_aRisk
650	0	4	_aThalidomide _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aDelimpasi, S
700	1		_aKatodritou, E
700	1		_aVassou, A
700	1		_aKyrtsonis, M C
700	1		_aRepousis, P
700	1		_aKartasis, Z
700	1		_aParcharidou, A
700	1		_aMichael, M
700	1		_aMichalis, E
700	1		_aGika, D
700	1		_aSymeonidis, A
700	1		_aPouli, A
700	1		_aKonstantopoulos, K
700	1		_aTerpos, E
700	1		_aKastritis, E
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 25 _gno. 1 _gp. 195-200
856	4	0	_uhttps://doi.org/10.1093/annonc/mdt483 _zAvailable from publisher's website
999			_c23384769 _d23384769